Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease – Cochrane Library Summary: Which combination of inhaled medications are safe and effective for chronic obstructive pulmonary disease (COPD)? – Cochrane Library  

The post SR | Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) vs. LABA plus inhaled corticosteroid (ICS) for COPD appeared first on Links Medicus.